Morgan Conn

Insider Reports History

Location
Leiden, Netherlands
Signature
/s/ Morgan Conn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Morgan Conn:

Company Role Class Num Shares Value Price $ Report Date Ownership
Century Therapeutics, Inc. Chief Finanical Officer Common Stock 79,648 $48,984 $0.6150 11 Mar 2025 Direct
Century Therapeutics, Inc. Chief Finanical Officer Stock Option (right to buy) 19,500 11 Mar 2025 Direct

Insider Reports Filed by Morgan Conn

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IPSC Century Therapeutics, Inc. 11 Mar 2025 2 $0 4 Chief Finanical Officer 12 Mar 2025, 19:31
IPSC Century Therapeutics, Inc. 14 Oct 2024 2 $0 4 Chief Finanical Officer 16 Oct 2024, 16:58
IPSC Century Therapeutics, Inc. 14 Oct 2024 0 $0 3 Chief Financial Officer 16 Oct 2024, 16:58